
What Does ‘Protection’ against COVID Really Mean?
To answer that question, expanded testing is needed that can determine levels of T immune cells
Esther Landhuis is a freelance science and health journalist based in the San Francisco Bay Area. Follow her on Twitter @elandhuis

To answer that question, expanded testing is needed that can determine levels of T immune cells

An individual’s health risks, treatment access and local case levels come into play for those who are eligible

But shortages mean that new antivirals and other drugs may be hard to come by

Researchers are still puzzling over what this drug does at the molecular level to help COVID patients

Over the past few years, the discipline has evolved in significant ways

New assays could reduce the need for costlier, more invasive brain scans and spinal fluid measures

The antiviral interferon might help early but exacerbate disease in later stages

Biotechs and pharma want to protect patients without triggering immune system havoc

New therapeutics are testing whether protective bacteria can dampen harmful immune responses to food

Clinical trials have begun to test drugs that counter toxic molecular webs linked to lung distress

New research in mice suggests that a pregnancy hormone contributes to brain and behavioral changes caused by childhood adversity

In mice, these white blood cells tamp down inflammation in the lungs

Long-ignored field attracts interest from companies trying to develop next-generation immune therapies

Mouse studies show tiny intercellular pods convey to sperm a legacy of a father’s hard knocks in life

Activating the reward system boosts anti-tumor immunity in mice

Drugs that disrupt production of toxic proteins in the brain could work for various degenerative disorders, including Alzheimer’s and Parkinson’s

Shutting down the top risk gene holds potential for halting the disease process

The computational immunologist Purvesh Khatri embraces messy data as a way to capture the messiness of disease. As a result, he’s making elusive genomic discoveries

A technology that uses magnetism to regulate neural activity shows a small benefit in patients with mild forms of the disease

Biological markers could enable tailored therapies that target individual differences in symptoms
Support science journalism.

Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account